Invention Grant
- Patent Title: Systems and methods for determining effects of therapies and genetic variation on polyadenylation site selection
-
Application No.: US17162224Application Date: 2021-01-29
-
Publication No.: US11322225B2Publication Date: 2022-05-03
- Inventor: Brendan Frey , Michael Ka Kit Leung
- Applicant: Deep Genomics Incorporated
- Applicant Address: CA Toronto
- Assignee: Deep Genomics Incorporated
- Current Assignee: Deep Genomics Incorporated
- Current Assignee Address: CA Toronto
- Agency: Wilson Sonsini Goodrich & Rosati
- Main IPC: G01N33/48
- IPC: G01N33/48 ; G01N33/50 ; G16B25/00 ; G06N20/00 ; G16B20/20 ; G16B40/00 ; G16B30/00 ; C12N15/113 ; C12Q1/6869 ; G06N3/00

Abstract:
The present disclosure provides systems and methods for determining effects of genetic variants on selection of polyadenylation sites (PAS) during polyadenylation processes. In an aspect, the present disclosure provides a polyadenylation code, a computational model that can predict alternative polyadenylation patterns from transcript sequences. A score can be calculated that describes or corresponds to the strength of a PAS, or the efficiency in which it is recognized by the 3′-end processing machinery. The polyadenylation model may be used, for example, to assess the effects of anti-sense oligonucleotides to alter transcript abundance. As another example, the polyadenylation model may be used to scan the 3′-UTR of a human genome to find potential PAS.
Public/Granted literature
Information query